Rx00045 - Bleomycin


Interactive 3D Model

Interactive Drug Target Network

Interactive Bipartite Drug Repurposing Graph

Rx00045
Primary Indication
Secondary Indication

Visualize Chemical Properties

Select x-axis

Select y-axis

Disease prevalence from Electronic Health Records

Click row to show all

Disease A Disease B A∩B A∩¬B B∩¬A Odds-Ratio P-Value Adjusted P-Value
lymphomas non-Hodgkin's lymphoma 4708 4708 6716 600.793 0 0.0
recurrent pleural effusions malignant pleural effusion 733 733 733 5504.671 0 0.0
embryonal cell Testicular Carcinoma teratocarcinoma 458 458 6096 661.897 0 0.0
Hodgkin's disease Hodgkin's lymphoma 1346 1346 1346 2997.715 0 0.0
non-Hodgkin's lymphoma Hodgkin's lymphoma 1346 6716 1346 600.793 0 0.0
Squamous cell carcinoma of neck Squamous cell carcinoma of head 312 312 312 12932.449 0 0.0
teratocarcinoma embryonal cell Testicular Carcinoma 458 6096 458 661.897 0 0.0
Squamous cell carcinoma of head Squamous cell carcinoma of neck 312 312 312 12932.449 0 0.0
malignant pleural effusion teratocarcinoma 82 733 6096 74.046 4.05E-118 1.3e-114

Shared Genetic Architectures of Disease Pairs

Click row to show all

Disease A Disease B Adjusted P-Value Shared Gene IDs
LYMPHOMAS NON-HODGKIN'S LYMPHOMA 9.64e-259 1231, ABCB1, ABCG2, ACAA1, ACBD3, ADAM17, ADAM19, ADH5, ADIPOQ, ADRB2, ADRB3, AHR, AICDA, AIF1, AKR1A1, AKR1C1, AKR1C3, ALDH1L1, ALOX12, ALOX12B, ALOX15, ALOX15B, ALOX5, ALOX5AP, ALOXE3, APEX1, APOA2, APOA4, APOB, APOE, AR, ATG9B, ATM, B3GNT3, BACH2, BAD, BAG1, BAG3, BAG4, BAG5, BAK1, BAX, BCL10, BCL2, BCL2A1, BCL2L1, BCL2L10, BCL2L11, BCL2L12, BCL2L13, BCL2L14, BCL2L2, BCL6, BCL7A, BCL7C, BCLAF1, BHMT, BID, BIK, BIRC3, BLM, BMF, BNIP2, BNIP3, BRAF, BRCA1, BRCA2, C14orf101, C1QA, C1QB, C1QC, C1QTNF7, C1RL, C1S, C2, C3, C3AR1, C4A, C4BPA, C4BPB, C5, C5AR1, C6, C6orf15, C7, C8B, C9, CARD11, CASP1, CASP10, CASP14, CASP2, CASP3, CASP4, CASP5, CASP6, CASP7, CASP8, CASP8AP2, CASP9, CAT, CBS, CCL1, CCL11, CCL13, CCL18, CCL2, CCL20, CCL24, CCL26, CCL5, CCL7, CCL8, CCND1, CCND3, CCR1, CCR2, CCR3, CCR4, CCR5, CCR6, CCR7, CCR8, CCR9, CD14, CD180, CD209, CD28, CD38, CD40, CD46, CD5, CD55, CD59, CD7, CD79A, CD79B, CD93, CDC42BPB, CDC6, CDH1, CDK2, CDK4, CDKN1A, CDKN1B, CDKN2A, CDKN2B, CEBPA, CETP, CFB, CFD, CFH, CFHR1, CFHR5, CFLAR, CHMP7, CHUK, CLCA1, CLCA2, CLDN9, CLU, COMT, CR1, CR2, CREB1, CRY2, CSF3, CTLA4, CTNNB1, CX3CR1, CXCL12, CXCL13, CXCR1, CXCR2, CXCR4, CXCR5, CYBA, CYP11B1, CYP11B2, CYP17A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP21A2, CYP24A1, CYP27B1, CYP2C19, CYP2C9, CYP2D6, CYP2E1, CYP3A4, CYP3A5, DCK, DEFA6, DEFB1, DEFB126, DFFB, DHFR, DICER1, DLG5, DNMT3A, DRD2, DRD3, DRD5, DROSHA, DUSP2, EDN1, EPHX1, EPHX2, ERCC1, ERCC2, ERCC3, ERCC4, ERCC5, ERCC6, ESR1, ESR2, ETS1, ETV6, EXOC2, EZH2, FAM179B, FBXW7, FCER1A, FCER1G, FCER2, FCGR2A, FCGR2B, FCGR3A, FCGR3B, FCGRT, FDFT1, FGF2, FGFR4, FGG, FLT1, FN1, FOXO1, FPGS, G6PD, GGH, GH1, GHR, GHRL, GOLGA7, GPC1, GPR44, GPX1, GPX2, GPX3, GPX4, GSTM1, GSTM3, GSTP1, GSTT1, H2AFX, HAVCR2, HDAC7, HES7, HLA-A, HLA-B, HLA-C, HLA-DPB1, HLA-DQA1, HLA-DQB1, HLA-DRB1, HMGCS1, HMGCS2, HP, HRAS, HRK, HSD17B1, HSD17B2, HSD3B1, HSD3B2, ICAM1, ICAM2, ICAM3, ICAM4, ICAM5, ICOS, IDH1, IDH2, IFNA1, IFNG, IFNGR1, IFNGR2, IGF1, IGF1R, IGF2, IGF2R, IGFBP1, IGFBP3, IGHV@, IKBKB, IL10, IL10RA, IL12A, IL12B, IL13, IL15, IL15RA, IL16, IL18, IL18RAP, IL1A, IL1B, IL1R1, IL1R2, IL1RN, IL2, IL21, IL3, IL4, IL4R, IL5, IL5RA, IL6, IL6R, IL7R, IL8, IL9, IL9R, INSL3, IRF4, IRF8, ITGB2, ITGB3, JAK2, JAK3, KDR, KIR2DL1, KIR2DL2, KIR2DL3, KIR2DL4, KIR2DL5A, KIR2DL5B, KIR2DP1, KIR2DS1, KIR2DS2, KIR2DS3, KIR2DS4, KIR2DS5, KIR3DL1, KIR3DL2, KIR3DL3, KIR3DP1, KIR3DS1, KRAS, KRT81, LEP, LEPR, LIG1, LIG3, LIG4, LIPC, LMO2, LNX2, LPL, LPXN, LSP1, LTA, LTBR, LY6G6F, MALT1, MAP3K5, MASP2, MBD2, MBL2, MBP, MC1R, MDM2, MGMT, MIF, MIR155, MIR202, MIR499, MITF, MLH1, MMP1, MMP2, MMP3, MMP9, MPO, MRE11A, MS4A1, MSH2, MSH3, MSH5, MSMB, MTHFD1, MTHFD2, MTHFR, MTHFS, MTR, MTRR, MYC, MYD88, NAT1, NAT2, NBN, NCF2, NCF4, NCOA1, NCOA3, NFKB1, NFKBIA, NFKBIB, NOD2, NOS1, NOS2, NOS3, NOTCH1, NOTCH2, NPAS2, NPC1, NPC2, NPY, NQO1, NR1H2, NR1H3, NR3C1, NRAS, OCA2, OGG1, PARD3, PARG, PARP1, PDSS1, PGR, PIM1, POMC, PON1, PPARG, PRF1, PRKAA2, PRKAG3, PRKDC, PRL, PRLR, PRRC2A, PSMB1, PTGDR, PTGES, PTGS1, PTGS2, PTP4A1, PTPN1, PVT1, RAC1, RAC2, RAD23B, RAD50, RAD51, RAD54L, RAET1L, RAG1, RAG2, RB1, REL, RFC1, RIPK1, RIPK2, RIPK3, RXRA, RYR3, SECTM1, SELE, SELP, SELPLG, SERPINA6, SERPING1, SETD8, SH2D1A, SHBG, SHMT1, SHMT2, SIRT1, SLC19A1, SLC23A1, SLC23A2, SLC3A2, SLC6A3, SLC7A5, SLC7A8, SLCO1B1, SLCO1B3, SOCS1, SOCS2, SOCS3, SOCS4, SOD1, SOD2, SOD3, SRD5A1, STAR, STARD3NL, STAT1, STAT2, STAT3, STAT4, STAT5A, STAT5B, STAT6, SUN2, TAF1, TAP2, TCN1, TERT, TET2, TGFB1, TICAM1, TIMP1, TIMP2, TIMP3, TLR1, TLR10, TLR2, TLR4, TLR6, TLR9, TNF, TNFAIP3, TNFAIP8, TNFRSF10A, TNFRSF14, TNFRSF17, TNFRSF1A, TNFRSF1B, TNFRSF8, TNFSF13B, TNFSF8, TOP2A, TP53, TP53I3, TRADD, TRAF1, TRAF2, TRAF5, TRAF6, TRAM1, TSLP, TSPO2, TYMS, TYR, UGT1A1, UNC13D, VCAM1, VDR, VEGFA, WRN, XPA, XPC, XRCC1, XRCC2, XRCC3, XRCC4, ZFP91
HODGKIN'S DISEASE HODGKIN'S LYMPHOMA 3.68e-220 ABCB1, AICDA, APEX1, ATM, BAX, BCL10, BCL2, BCL2A1, BCL2L1, BCL2L10, BCL2L11, BCL2L2, BCL6, BCL7A, BCL7C, BLM, BLMH, BMF, BRCA1, BRCA2, CASP1, CASP14, CASP2, CASP3, CASP4, CASP5, CASP6, CASP7, CASP8, CASP8AP2, CASP9, CAST, CCL17, CCND1, CCNH, CD14, CD28, CD4, CD40, CD5, CD70, CD79A, CD79B, CD81, CFLAR, CHEK2, CHUK, CXCL12, CXCR1, CXCR2, CYP1A1, CYP2C9, CYP2D6, CYP2E1, CYP3A4, EOMES, EPHX1, ERAP1, ERCC1, ERCC2, ERCC3, ERCC5, ERCC6, FADD, FAS, FASLG, FCGR2A, FGFR2, FLJ45983, GATA3, GPX1, GPX2, GPX3, GPX4, GSTA1, GSTM1, GSTP1, GSTT1, HBS1L, HCG9, HFE, HLA-A, HLA-B, HLA-C, HLA-DPB1, HLA-DQA1, HLA-DQB1, HLA-DRA, HLA-DRB1, HPSE, ICAM1, IFNG, IKBKB, IL10, IL10RA, IL10RB, IL12A, IL12B, IL12RB1, IL12RB2, IL13, IL15, IL18, IL19, IL1A, IL1B, IL1R1, IL1R2, IL1RN, IL2, IL4, IL4R, IL5, IL6, IL6R, IL6ST, IL8, IL9, IRF4, ITGA6, JAK3, KRT81, LIG1, LIG3, LIG4, LMO2, LMTK2, LTA, LTC4S, MDM2, MGMT, MICB, MLH1, MRE11A, MS4A2, MTHFR, MTR, MYB, MYC, MYD88, NBN, NFKB1, NFKB2, NFKBIA, NFKBIE, NFRKB, NQO1, OGG1, PARP1, PIM1, PKNOX2, POLB, PPARG, PRKDC, PTGS2, PTPN1, PVT1, RAD50, RAD51, RAD54L, RAG1, RAG2, REL, RELA, RELB, RIPK1, RIPK2, RPL13P2, SHMT1, SOCS1, STAT1, STAT3, STAT5A, STAT6, TANK, TARBP2, TERT, TFRC, TGFB1, TLR1, TLR10, TLR2, TLR3, TLR4, TLR6, TLR7, TLR8, TLR9, TNF, TNFRSF10A, TNFRSF10B, TNFRSF10C, TNFRSF10D, TNFRSF12A, TNFRSF13B, TNFRSF13C, TNFRSF14, TNFRSF18, TNFRSF9, TNFSF10, TNFSF13, TNFSF14, TNFSF18, TNFSF4, TNFSF8, TNFSF9, TP53, TP53I3, TRADD, TRAF2, TRAF5, TRAF6, TYMS, UGT1A1, UGT1A6, VCAM1, VEGFA, WRN, XPC, XPO5, XRCC1, XRCC2, XRCC3, XRCC4
NON-HODGKIN'S LYMPHOMA HODGKIN'S LYMPHOMA 5.39e-100 ABCB1, AICDA, APEX1, ATM, BAX, BCL10, BCL2, BCL2A1, BCL2L1, BCL2L10, BCL2L11, BCL2L2, BCL6, BCL7A, BCL7C, BLM, BMF, BRCA1, BRCA2, CASP1, CASP14, CASP2, CASP3, CASP4, CASP5, CASP6, CASP7, CASP8, CASP8AP2, CASP9, CCND1, CD14, CD28, CD40, CD5, CD79A, CD79B, CFLAR, CHUK, CXCL12, CXCR1, CXCR2, CYP1A1, CYP2C9, CYP2D6, CYP2E1, CYP3A4, EPHX1, ERCC1, ERCC2, ERCC3, ERCC5, ERCC6, FCGR2A, GPX1, GPX2, GPX3, GPX4, GSTM1, GSTP1, GSTT1, HLA-A, HLA-B, HLA-C, HLA-DPB1, HLA-DQA1, HLA-DQB1, HLA-DRB1, ICAM1, IFNG, IKBKB, IL10, IL10RA, IL12A, IL12B, IL13, IL15, IL18, IL1A, IL1B, IL1R1, IL1R2, IL1RN, IL2, IL4, IL4R, IL5, IL6, IL6R, IL8, IL9, IRF4, JAK3, KRT81, LIG1, LIG3, LIG4, LMO2, LTA, MDM2, MGMT, MLH1, MRE11A, MTHFR, MTR, MYC, MYD88, NBN, NFKB1, NFKBIA, NQO1, OGG1, PARP1, PIM1, PPARG, PRKDC, PTGS2, PTPN1, PVT1, RAD50, RAD51, RAD54L, RAG1, RAG2, REL, RIPK1, RIPK2, SHMT1, SOCS1, STAT1, STAT3, STAT5A, STAT6, TERT, TGFB1, TLR1, TLR10, TLR2, TLR4, TLR6, TLR9, TNF, TNFRSF10A, TNFRSF14, TNFSF8, TP53, TP53I3, TRADD, TRAF2, TRAF5, TRAF6, TYMS, UGT1A1, VCAM1, VEGFA, WRN, XPC, XRCC1, XRCC2, XRCC3, XRCC4

Chemical, Pharmacological and Biological Annotations


ATC Code:
L01DC01
Brands:
Blenoxane; Bleo
Category:
Antibiotics, Antineoplastic
ChEBI ID:
22907
PubChem ID:
5360373
SMILE:
C[C@@H](O)[C@H](NC(=O)[C@@H](C)[C@H](O)[C@@H](C)NC(=O)[C@@H](NC(=O)C1=C(C)C(N)=NC(=N1)[C@H](CC(N)=O)NC[C@H](N)C(N)=O)[C@@H](OC1OC(CO)C(O)C(O)C1OC1OC(CO)C(O)C(OC(N)=O)C1O)C1=CN=CN1)C(=O)NCCC1=NC(=CS1)C1=NC(=CS1)C(=O)NCCC[S+](C)C
InChI:
1S/C55H83N17O21S3/c1-20-33(69-46(72-44(20)58)25(12-31(57)76)64-13-24(56)45(59)82)50(86)71-35(41(26-14-61-19-65-26)91-54-43(39(80)37(78)29(15-73)90-54)92-53-40(81)42(93-55(60)88)38(79)30(16-74)89-53)51(87)66-22(3)36(77)21(2)47(83)70-34(23(4)75)49(85)63-10-8-32-67-28(18-94-32)52-68-27(17-95-52)48(84)62-9-7-11-96(5)6/h14,17-19,21-25,29-30,34-43,53-54,64,73-75,77-81H,7-13,15-16,56H2,1-6H3,(H13-,57,58,59,60,61,62,63,65,66,69,70,71,72,76,82,83,84,85,86,87,88)/p+1/t21-,22+,23+,24-,25-,29?,30?,34-,35-,36-,37?,38?,39?,40?,41-,42?,43?,53?,54?/m0/s1
Classification:
Kingdom:
Organic Compounds
Superclass:
Organic Acids and Derivatives
Class:
Carboxylic Acids and Derivatives
Subclass:
Amino Acids, Peptides, and Analogues
Indication:
For palliative treatment in the management malignant neoplasm (trachea, bronchus, lung), squamous cell carcinoma, and lymphomas.
Pharmacodynamics:
Bleomycin is an antibiotic which has been shown to have antitumor activity. Bleomycin selectively inhibits the synthesis of deoxyribonucleic acid (DNA). The guanine and cytosine content correlates with the degree of mitomycin-induced cross-...
Click to show more...
Description:
A complex of related glycopeptide antibiotics from <i>Streptomyces verticillus</i> consisting of bleomycin A2 and B2 (B2 CAS # 9060-10-0). It inhibits DNA metabolism and is used as an antineoplastic, especially for solid tumors. Bleomycin A...
Click to show more...
Mechanism:
Although the exact mechanism of action of bleomycin is unknown, available evidence would seem to indicate that the main mode of action is the inhibition of DNA synthesis with some evidence of lesser inhibition of RNA and protein synthesis. ...
Click to show more...

Adsorption, Distribution, Metabolism, Excretion and Toxicity


Human Intestinal Absorption:
-
Blood Brain Barrier:
-
Caco-2 permeable:
-
P-glycoprotein substrate:
Substrate
P-glycoprotein inhibitor I:
Non-inhibitor
P-glycoprotein inhibitor II:
Non-inhibitor
Renal organic cation transporter:
Non-inhibitor
CYP450 2C9 substrate:
Non-inhibitor
CYP450 2D6 substrate:
Non-inhibitor
CYP450 2C19 substrate:
Non-inhibitor
CYP450 inhibitory promiscuity:
Low CYP Inhibitory Promiscuity
Ames test:
AMES toxic
Carcinogenicity:
Non-carcinogens
Biodegradation:
Not ready biodegradable
Rat acute toxicity:
2.6132 LD50, mol/kg
hERG inhibition (predictor I):
Weak inhibitor
hERG inhibition (predictor II):
Inhibitor

Contact Us:
Please contact us if you have questions or comments about RepurposeDB. You can also contact us if you need help in submitting your drug repositioning investigation to RepurposeDB.


Dudley Laboratory
Department of Genetics and Genomic Sciences
Icahn Institute for Genomics and Multiscale Biology
Icahn School of Medicine at Mount Sinai
One Gustave L. Levy Place, Box 1498
Manhattan, New York City, NY
repurposedb@dudleylab.org